tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Hypertension D006973 115 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Glomerulosclerosis, Focal Segmental D005923 4 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Dermatitis D003872 30 associated lipids
Gastrointestinal Diseases D005767 20 associated lipids
Vomiting D014839 21 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Pharyngitis D010612 2 associated lipids
Shock D012769 11 associated lipids
Erythema D004890 22 associated lipids
Dermatomycoses D003881 17 associated lipids
Hyperalgesia D006930 42 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Cholelithiasis D002769 16 associated lipids
Fever D005334 35 associated lipids
Amenorrhea D000568 4 associated lipids
Dermatitis, Seborrheic D012628 10 associated lipids
Thrombocytopenia D013921 15 associated lipids
Hyperlipidemias D006949 73 associated lipids
Shock, Septic D012772 11 associated lipids
Ileal Neoplasms D007078 2 associated lipids
Cough D003371 19 associated lipids
Paraproteinemias D010265 2 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Translocation, Genetic D014178 20 associated lipids
Catalepsy D002375 30 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Ovarian Cysts D010048 4 associated lipids
Precursor Cell Lymphoblastic Leukemia-Lymphoma D054198 10 associated lipids
Cardiomegaly D006332 31 associated lipids
Hypertension, Renal D006977 9 associated lipids
Metaplasia D008679 7 associated lipids
Burkitt Lymphoma D002051 15 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Tachycardia D013610 7 associated lipids
Cicatrix D002921 9 associated lipids
Neutropenia D009503 15 associated lipids
Peritoneal Neoplasms D010534 16 associated lipids
Arthritis, Juvenile D001171 8 associated lipids
Urticaria D014581 13 associated lipids
Behcet Syndrome D001528 7 associated lipids
Fetal Hypoxia D005311 3 associated lipids
Thrombophlebitis D013924 6 associated lipids
Cardiomyopathy, Hypertrophic D002312 6 associated lipids
HIV Seropositivity D006679 15 associated lipids
Uveitis D014605 14 associated lipids
Enterobacteriaceae Infections D004756 5 associated lipids
Alveolar Bone Loss D016301 10 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Uno T et al. The pharmacokinetics of water-in-oil-in-water-type multiple emulsion of a new tacrolimus formulation. 1997 Lipids pmid:9168461
Freiberg RA et al. Transcriptional control in keratinocytes and fibroblasts using synthetic ligands. 1997 J. Clin. Invest. pmid:9169490
Wang JH and Kelly PT Postsynaptic calcineurin activity downregulates synaptic transmission by weakening intracellular Ca2+ signaling mechanisms in hippocampal CA1 neurons. 1997 J. Neurosci. pmid:9169521
Dodd DA Rapid resolution of gingival hyperplasia after switching from cyclosporine A to tacrolimus. 1997 J. Heart Lung Transplant. pmid:9171281
Savoldi E et al. [Dental and oral aspects in pediatric liver transplant patients. A comparison between the effects of cyclosporine A and FK 506]. 1997 Minerva Stomatol pmid:9173223
Rezeig MA et al. Kaposi's sarcoma in liver transplant recipients on FK506: two case reports. 1997 Transplantation pmid:9175820
Aoki Y and Kao PN Cyclosporin A-sensitive calcium signaling represses NFkappaB activation in human bronchial epithelial cells and enhances NFkappaB activation in Jurkat T-cells. 1997 Biochem. Biophys. Res. Commun. pmid:9177287
Prasad NV et al. Metabolism of tacrolimus (FK 506) in rat liver microsomes. Effect of rifampin and dexamethasone. 1997 Res. Commun. Mol. Pathol. Pharmacol. pmid:9178371
Scott JE et al. Dynamic equilibrium between calcineurin and kinase activities regulates the phosphorylation state and localization of the nuclear factor of activated T-cells. 1997 Biochem. J. pmid:9182723
Suzuki N et al. In vivo mechanisms for the inhibition of T lymphocyte activation by long-term therapy with tacrolimus (FK-506): experience in patients with Behçet's disease. 1997 Arthritis Rheum. pmid:9182928
Odom A et al. Calcineurin is required for virulence of Cryptococcus neoformans. 1997 EMBO J. pmid:9184205
Nishinaka H et al. Graft persistence effectively induces and maintains donor-specific unresponsiveness. 1997 J. Surg. Res. pmid:9184673
Miwa S et al. Effect of anti-intercellular adhesion molecule-1 and anti-leukocyte function associated antigen-1 monoclonal antibodies on rat-to-mouse cardiac xenograft rejection. 1997 Surgery pmid:9186469
Fujino H et al. Stimulatory roles of muscarinic acetylcholine receptors on T cell antigen receptor/CD3 complex-mediated interleukin-2 production in human peripheral blood lymphocytes. 1997 Mol. Pharmacol. pmid:9187267
Hausen B and Morris RE Review of immunosuppression for lung transplantation. Novel drugs, new uses for conventional immunosuppressants, and alternative strategies. 1997 Clin. Chest Med. pmid:9187827
Elmer DS et al. Use of FK506 immunosuppressive therapy in pancreas transplantation. 1996 J Transpl Coord pmid:9188369
Cohen SB et al. Autocrine and paracrine regulation of human T cell IL-10 production. 1997 J. Immunol. pmid:9190906
Ballantyne CM et al. Pathophysiology and treatment of lipid perturbation after cardiac transplantation. 1997 Curr. Opin. Cardiol. pmid:9192484
Taylor DO The use of tacrolimus and mycophenolate mofetil after cardiac transplantation. 1997 Curr. Opin. Cardiol. pmid:9192485
Hayashi S et al. Adenovirus-mediated gene transfer to the xenogeneic liver in liver xenotransplantation: the transduction of complement regulatory factor genes (DAF and HRF20). 1997 Transplant. Proc. pmid:9193595
Hohage H et al. Effects of cyclosporin A and FK 506 on lipid metabolism and fibrinogen in kidney transplant recipients. 1997 Clin Transplant pmid:9193847
Katari SR et al. Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients. 1997 Clin Transplant pmid:9193849
Ciancio G et al. Post-transplant lymphoproliferative disease in kidney transplant patients in the new immunosuppressive era. 1997 Clin Transplant pmid:9193850
Koneru B et al. Blood transfusions in liver recipients: a conundrum or a clear benefit in the cyclosporine/tacrolimus era? 1997 Transplantation pmid:9197350
Sugitani A et al. En bloc pancreas and kidney transplantation in a patient with limited vascular access. 1997 Transplantation pmid:9197366
Guerini D Calcineurin: not just a simple protein phosphatase. 1997 Biochem. Biophys. Res. Commun. pmid:9199180
Rouviere N et al. Immunosuppressor binding to the immunophilin FKBP59 affects the local structural dynamics of a surface beta-strand: time-resolved fluorescence study. 1997 Biochemistry pmid:9200682
Alak AM Measurement of tacrolimus (FK506) and its metabolites: a review of assay development and application in therapeutic drug monitoring and pharmacokinetic studies. 1997 Ther Drug Monit pmid:9200777
Raufman JP et al. Regulation of calcium-induced exocytosis from gastric chief cells by protein phosphatase-2B (calcineurin). 1997 Biochim. Biophys. Acta pmid:9202177
Mochizuki M Immunotherapy for Behçet's disease. 1997 Int. Rev. Immunol. pmid:9203026
Nussenblatt RB Uveitis in Behçet's disease. 1997 Int. Rev. Immunol. pmid:9203027
Araki T et al. Age-related changes of sodium-dependent D-[3H]aspartate and [3H]FK506 binding in rat brain. 1997 J Neural Transm pmid:9203087
Moroda T et al. Self-reactive forbidden clones are confined to pathways of intermediate T-cell receptor cell differentiation even under immunosuppressive conditions. 1997 Immunology pmid:9203970
Mrvos R et al. Tacrolimus (FK 506) overdose: a report of five cases. 1997 J. Toxicol. Clin. Toxicol. pmid:9204100
Sikorski R and Peters R A cell growth switch. 1997 Science pmid:9206844
Shafiee A et al. Chemical and biological characterization of two FK506 analogs produced by targeted gene disruption in Streptomyces sp. MA6548. 1997 J. Antibiot. pmid:9207912
Uberti JP et al. Tacrolimus and methotrexate for the prophylaxis of acute graft-versus-host disease in allogeneic bone marrow transplantation in patients with hematologic malignancies. 1997 Bone Marrow Transplant. pmid:9208118
Ellouk-Achard S et al. Implication of CYP 3A in the toxicity of cyclosporin G (CsG), cyclosporin A (CsA) and FK506 on rat hepatocytes in primary culture. 1997 Arch. Toxicol. pmid:9209689
Devine SM et al. The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis. 1997 Biol. Blood Marrow Transplant. pmid:9209738
Su Y et al. Cyclosporin A but not FK506 inhibits thyroid hormone-induced apoptosis in tadpole intestinal epithelium. 1997 FASEB J. pmid:9212079
Maeda T [Experimental study of the effectiveness of immunosuppression therapy using FK506 and 15-deoxyspergualin in concordant xenotransplantation]. 1997 Nihon Kyobu Geka Gakkai Zasshi pmid:9217381
duBell WH et al. Effect of the immunosupressant FK506 on excitation-contraction coupling and outward K+ currents in rat ventricular myocytes. 1997 J. Physiol. (Lond.) pmid:9218211
Hebebrand D et al. Nerve xenograft transplantation. Immunosuppression with FK-506 and RS-61443. 1997 J Hand Surg Br pmid:9222906
Rejto PA and Verkhivker GM Mean field analysis of FKBP12 complexes with FK506 and rapamycin: implications for a role of crystallographic water molecules in molecular recognition and specificity. 1997 Proteins pmid:9223178
Birnbaum AH et al. Recurrence of autoimmune hepatitis in children after liver transplantation. 1997 J. Pediatr. Gastroenterol. Nutr. pmid:9226522
Wingard JR et al. Lack of interaction between tacrolimus (FK506) and methotrexate in bone marrow transplant recipients. 1997 Bone Marrow Transplant. pmid:9232256
Yamagami S et al. Mechanism of concordant corneal xenograft rejection in mice: synergistic effects of anti-leukocyte function-associated antigen-1 monoclonal antibody and FK506. 1997 Transplantation pmid:9233699
Sawabe T et al. Sinus arrest during tacrolimus (FK506) and digitalis treatment in a bone marrow transplant recipient. 1997 Transplantation pmid:9233725
Kogi M et al. Effects of calyculin A and FK506 on the O2- generation of rat peritoneal macrophages. 1996 Tokai J. Exp. Clin. Med. pmid:9239803
Tsubo T et al. Elimination of FK-506 by continuous hemodiafiltration in a liver transplant patient. 1997 Jul-Aug ASAIO J. pmid:9242954